Bosh sahifaA2LC34 • BVMF
add
Alcon Inc
Yopilish kursi
43,20 R$
Yillik diapazon
43,20 R$ - 55,60 R$
Bozor kapitalizatsiyasi
31,18 mlrd CHF
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,60 mlrd | 4,01% |
Joriy xarajat | 1,14 mlrd | 8,98% |
Sof foyda | 176,00 mln | -21,08% |
Sof foyda marjasi | 6,78 | -24,08% |
Har bir ulushga tushum | 0,76 | 2,70% |
EBITDA | 629,00 mln | 1,94% |
Amaldagi soliq stavkasi | 11,56% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,41 mlrd | 2,62% |
Jami aktivlari | 31,39 mlrd | 5,62% |
Jami passivlari | 9,26 mlrd | 5,47% |
Umumiy kapital | 22,13 mlrd | — |
Tarqatilgan aksiyalar | 494,40 mln | — |
Narxi/balansdagi bahosi | 0,97 | — |
Aktivlardan daromad | 2,32% | — |
Kapitaldan daromad | 2,65% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 176,00 mln | -21,08% |
Operatsiyalardan naqd pul | 505,00 mln | -4,72% |
Sarmoyadan naqd pul | -154,00 mln | -15,79% |
Moliyadan naqd pul | -383,00 mln | -123,98% |
Naqd pulning sof oʻzgarishi | -4,00 mln | -101,73% |
Boʻsh pul | 336,38 mln | -10,57% |
Haqida
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Tashkil etilgan
1945
Bosh ofis
Sayt
Xodimlar soni
25 000
